You are here

InterMune

InterMune Gearing Up For Another Round With The FDA

Yahoo/Reuters

Thu, 11/29/12 - 12:03 pm

idiopathic pulmonary fibrosis

Can InterMune Sustain Positive Momentum?

Seeking Alpha

Wed, 11/21/12 - 12:17 pm

3 Humongous Health-Care Stocks This Week

Motley Fool

Sat, 11/10/12 - 08:19 am

Esbriet Sales Demonstrating Growth; Expansion into New Markets Continues

Yahoo/Reuters

Fri, 11/9/12 - 11:21 am

3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out

Seeking Alpha

Mon, 09/17/12 - 11:05 am

Is the Price Finally Right to Buy InterMune?

Motley Fool

Sat, 08/11/12 - 11:19 am

6 Biotech Stocks That Analysts Give The Green Light

Seeking Alpha

Fri, 07/27/12 - 12:05 pm

Seattle Genetics

InterMune: Weak Esbriet Sales But In-Line Pricing

TheStreet.com

Mon, 07/23/12 - 09:01 am

InterMune Second Quarter Earnings Sneak Peek

Wall St. Cheat Sheet

Wed, 07/18/12 - 12:13 pm

Intermune Concludes Sale of Actimmune

Yahoo/Zacks

Sat, 06/23/12 - 11:48 am

InterMune to Sell Actimmune Rights

Yahoo/Zacks.com

Tue, 05/22/12 - 09:40 am

Drug Approval! Oh, Wait, We Knew That Already.

Motley Fool

Sat, 05/12/12 - 12:34 pm

Cell Therapeutics

Why InterMune Shares Got Crushed

Motley Fool

Sat, 04/28/12 - 11:41 am

InterMune Inc. First Quarter Earnings Sneak Peek

Wall St. Cheat Sheet

Mon, 04/23/12 - 12:13 pm

Why InterMune Shares Plunged

Motley Fool

Mon, 04/9/12 - 12:14 pm

Drug Pricing Takes This Biotech on a Rollercoaster

Motley Fool

Sat, 03/17/12 - 10:38 am

idiopathic pulmonary fibrosis

3 Lessons From the J.P. Morgan Health-Care Confab

Motley Fool

Mon, 01/16/12 - 10:43 am

InterMune's Esbriet rings up $2.8 million in sales since mid-September launch in Germany

Yahoo/AP

Thu, 01/5/12 - 01:01 pm

idiopathic pulmonary fibrosis

Pages